Transcriptomic studies and proliferation and marker analyses all indicate that reduction of SOX2 dosage compromises most aspects of tumorigenesis in p27−/− animals, implying an essential role for SOX2 in p27−/− melanotrophs and adjacent SCs for tumor development. This evidence concerns the gene SOX2 and neoplasm.